Cyclodipeptides are secondary metabolites biosynthesized by many bacteria and exhibit a wide array of biological activities. Recently, a new class of small proteins, named cyclodipeptide synthases (CDPS), which are unrelated to the typical nonribosomal peptide synthetases, was shown to generate several cyclodipeptides, using aminoacyl-tRNAs as substrates. The Mycobacterium tuberculosis CDPS, Rv2275, was found to generate cyclodityrosine through the formation of an aminoacyl-enzyme intermediate and to have a structure and oligomeric state similar to those of the class Ic aminoacyl-tRNA synthetases (aaRSs). However, the poor sequence conservation among CDPSs has raised questions about the architecture and catalytic mechanism of the identified homologs. Here we report the crystal structures of Bacillus licheniformis CDPS YvmC-Blic, in the apo form and complexed with substrate mimics, at 1.7-2.4-Å resolutions. The YvmC-Blic structure also exhibits similarity to the class Ic aaRSs catalytic domain. Our mutational analysis confirmed the importance of a set of residues for cyclodileucine formation among the conserved residues localized in the catalytic pocket. Our biochemical data indicated that YvmC-Blic binds tRNA and generates cyclodileucine as a monomer. We were also able to detect the presence of an aminoacyl-enzyme reaction intermediate, but not a dipeptide tRNA intermediate, whose existence was postulated for Rv2275. Instead, our results support a sequential catalytic mechanism for YvmC-Blic, with the successive attachment of two leucine residues on the enzyme via a conserved serine residue. Altogether, our findings suggest that all CDPS enzymes share a common aaRS-like architecture and a catalytic mechanism involving the formation of an enzyme-bound intermediate.
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X-ray crystallography | pulcherrimin | diketopiperazine | divergent evolution | thioesterase domain C yclodipeptides belong to the diketopiperazine (DKP) family of secondary metabolites that are produced in many bacteria. This class of compounds has recently gained interest due to its wide array of biological activities, including antibacterial, antifungal, antiviral, antiprion, antitumor, and immunosuppressive functions (1, 2) . Most cyclodipeptide biosynthesis pathways involve nonribosomal peptide synthetases (NRPSs) (3, 4) . NRPSs are large multifunctional modular enzymes in which each module catalyzes a single step of peptide synthesis by incorporating one amino acid. In the standard NRPS module, the peptide bondforming condensation domain (C) and the amino acid adenylation domain (A) are linked through a phosphopantetheinetethered domain (T) to synthesize the peptidyl chain as a growing thioester. The enzyme usually ends with a thioesterase domain (TE), which releases the peptidyl chain by hydrolysis or cyclization (5) .
However, in 2002 Lautru et al. identified the albC gene in the genome of the bacterium Streptomyces noursei, and its product AlbC, which lacked similarity to the NRPSs, was able to catalyze the formation of a cyclic dipeptide (6) . AlbC is the first enzyme in the biosynthetic pathway of albonoursin, a secreted antibacterial DKP bearing a cyclodipeptide structure. Recently, AlbC was shown to use aminoacylated tRNAs as substrates instead of free amino acids (7) , thus allowing the enzyme to skip the amino acid activation step usually performed by the adenylation domain in NRPSs. Mining of bacterial genomes identified seven other potentially homologous proteins sharing only 20 to 26% sequence identity with AlbC. They were all shown to use aminoacyl-tRNAs to generate a variety of cyclodipeptides (7) and have been named cyclodipeptide synthases (CDPSs). Although other enzymes have been reported to divert aminoacylated tRNAs from their primary use in the translation process [e.g., the FemXAB family, participating in peptidoglycan synthesis (8) ; the L/F-transferases, involved in protein turnover (9) ], they lack sequence similarity with the CDPS enzymes. In addition, CDPSs are peculiar because they bring tRNA into the secondary metabolism.
The structure of the Mycobacterium tuberculosis CDPS, Rv2275, was recently solved (10), revealing a striking structural similarity to the catalytic domains of the class Ic aminoacyltRNA synthetases (aaRSs; i.e., tyrosyl-and tryptophanyl-tRNA synthetases, TyrRS, and TrpRS), although they share less than 15% sequence identity between them. Rv2275 forms a dimer and catalyzes the formation of cyclodityrosine (cYY), by the transient attachment of the tyrosine moiety to a serine residue in the active site. The authors proposed a catalytic mechanism that involves the formation of a dityrosine-tRNA intermediate.
Bacillus licheniformis YvmC-Blic is another CDPS enzyme that catalyzes the formation of cyclodileucine (cLL), by employing two Leu-tRNA Leu molecules (7) . cLL is a precursor of pulcherrimin (Fig. 1) , a red extracellular pigment formed by several species of bacteria (including B. licheniformis) after growth in Fe 3þ ion-enriched media. This pathway was best characterized in Bacillus subtilis (11) . First, YvmC-Bsub catalyzes the formation of cLL from Leu-tRNA Leu (7). The cytochrome P450 CypX then oxidizes cLL into pulcherriminic acid (12) , which is released in the medium and reacts with an Fe 3þ ion to produce pulcherrimin. In B. subtilis, B. licheniformis, and other related bacteria, the cypX gene is located downstream of the yvmC gene (7) .
We now report the structure of YvmC-Blic, which also resembles those of the catalytic domains of the class Ic aaRSs, despite the poor sequence similarity. Our biochemical data indicated that cLL formation by YvmC-Blic did not require either ATP or freestanding amino acids. Mutational analyses revealed a set of CDPS-specific residues that recognize the aminoacyl moiety and catalyze its transient attachment to a conserved serine residue. Analyses by mass spectrometry failed to detect the dileucinetRNA intermediate, prompting us to propose a different catalytic mechanism from that postulated for cYY formation by Rv2275 (10) . Altogether, our findings suggest that all CDPS enzymes share a common aaRS-like architecture and a catalytic mechanism involving the formation of an enzyme-bound intermediate.
Results and Discussion
The Architecture of YvmC-Blic Is Similar to That of a Class Ic aaRS Catalytic Domain. The crystal structures of B. licheniformis CDPS YvmC-Blic, in the apo form and in the complexes with 2-(N-cyclohexylamino)ethane sulfonic acid (CHES) and 3-(cyclohexylamino)-2-hydroxy-1-propanesulfonic acid (CAPSO), were determined at 1.9-, 1.7-, and 2.4-Å resolutions, respectively (PDB IDs 3OQH, 3OQI, 3OQJ) (Table S1 ). In all structures, the 11 N-terminal and 14 C-terminal residues are disordered. The asymmetric unit contains one or two monomers of YvmCBlic, depending on the crystal form (Fig. S1 ). The YvmC-Blic structure exhibits striking structural similarity with those of the class Ic aaRS catalytic domains, consisting of an α/β fold with six strand-helix units, but it lacks the last helix and the helical inserts before and after the fourth strand, as compared with the aaRS catalytic domain (Fig. 2 A and B) . The YvmC-Blic structure superimposed well on those of several eukaryotic TyrRSs and TrpRSs, despite the low sequence identity (less than 15%). For instance, the superimposition of the YvmC-Blic structure on those of Saccharomyces cerevisiae TyrRS (PDB ID code 2DLC) and TrpRS (PDB ID code 3KT6) yielded rms deviations of the Cα atoms of 3.4 and 3.6 Å over 182 and 176 residues, respectively (Fig. S2A) .
However, a structural comparison of YvmC-Blic and yeast TyrRS revealed several important differences. First, both class I aaRS signature motifs (i.e., HIGH and KMSKS) are absent in YvmC-Blic, and most of the residues specific to the class Ic aaRSs are not conserved (13, 14) . Second, the YvmC-Blic catalytic pocket lacks the residues that bind ATP in TyrRSs and is too small to accommodate ATP (Fig. S2A) . Third, YvmC-Blic contains a long, flexible loop at the end of the CP1 insertion of the class Ic aaRSs. The loop adopts a different conformation in each structure, partly due to the intermolecular crystal contacts, and is always disordered in one of the monomers in the asymmetric unit (Fig. S2B) . The loop is localized at the top of the catalytic pocket, suggesting a role analogous to that of the KMSKS loop in classI aaRSs (i.e., covering the catalytic pocket during the two-step reaction mechanism). Fourth, the long helix at the "back" of YvmC-Blic is rich in positively charged residues and might form the tRNA-binding surface (Fig. S2C) . CDPS sequences usually contain a number of basic residues in this loop (Fig. S3) , suggesting a similar tRNA-binding mode for all CDPSs. These differences may account for the functional differences observed in the reactions catalyzed by CDPSs and aaRSs.
Despite the moderate sequence identity (27%) (Table S2) , YvmC-Blic and Rv2275 exhibit high structural similarity, with an rms deviation of 2.2 Å for 211 Cα atoms (Fig. S2D ). Both CDPS structures also share a similarly twisted β-sheet, as compared to that of the TyrRSs (Fig. S2E) . This observation suggests a conserved architecture for all CDPSs. The major difference between both CDPSs is the conformation of the helix α6 and the following flexible loop covering the catalytic pocket, which might reflect their respective substrate specificities.
CHES and CAPSO Bind in the Catalytic Pocket. Intriguingly, the buffer molecules CHES and CAPSO, which were critical for growing the YvmC-Blic crystals, were both clearly visible in the respective electron density maps (Fig. 2 C and D) . Two CHES molecules were bound to each monomer of CDPS, one in the catalytic pocket and the other one at the border of the pocket, mediating the crystallographic contacts with a symmetric CDPS molecule. The cyclohexane ring of the first CHES molecule forms van der Waals contacts with the main chains of Gly35 and Leu65, while its main chain nitrogen atom hydrogen bonds with the side chains of Tyr180 and Glu184. The sulfate oxygen atoms of the CHES molecule hydrogen bond with the Arg206 and Asn40 amide groups and the Tyr204 hydroxyl group. The cyclohexane ring of the second CHES molecule interacts hydrophobically with the side chains of Arg206 and Pro207 and with Met131, Glu134, and Ala135 from the symmetric molecule. The oxygen atoms of the sulfate group hydrogen bond with the main chains of Lys209 and Leu210. In the CAPSO-bound structure, the CAPSO cyclohexane ring interacts hydrophobically with the Gly35 main chain and the Leu65 and Phe188 side chains, while its main chain nitrogen and oxygen atoms hydrogen bond with the Glu184 carboxyl groups. One oxygen atom of the sulfate group hydrogen bonds with the Arg206 amino group. Notably, the positions of the cyclohexane rings in the first CHES and the CAPSO molecules correspond to the positions of the side chains of the bound Tyr and Trp molecules in the catalytic sites of the corresponding aaRSs. Furthermore, Phe is one of the amino acids used by YvmC-Blic to generate cyclodipeptides. These observations suggest that the two buffer molecules mimic the aminoacyl moieties of the physiological substrates.
The hydrophobic residues at the bottom of the pocket are loosely conserved, which may explain the relaxed specificity of the CDPSs. A superimposition of the YvmC-Blic and yeast TyrRS structures suggests the functional conservation of Yvmc-Blic Tyr180 and Glu184 for recognizing the amide group of the Leu moiety in Leu-tRNA Leu (Fig. 2E) . A comparison of the residues around the catalytic pocket between Rv2275 and YvmC-Blic revealed the conservation of several residues located at the entrance of the pocket, which are likely to be involved in the catalytic mechanism (see below). In the Rv2275 catalytic pocket, Asn251 was proposed to recognize the hydroxyl group of the substrate tyrosyl moiety (10). Asn251 is replaced by Leu202 in YvmC-Blic (Fig. 2E) , and the Leu residue is conserved among the cLL-producing CDPSs (Fig. S3) (7) . This observation suggests that the residue at this position is involved in defining the CDPS substrate specificity. Despite repeated crystallization trials in the presence of small ligands, we were unable to obtain any consistent electron density for the free amino acids or aminoacyl-tRNA mimics in the pocket. Rv2275 was also crystallized only in the absence of ligands. The narrow access to the pocket in the solved structures suggests that they represent a "closed" state of the enzyme, which might require tRNA binding to open.
YvmC-Blic Is Active as a Monomer. Previous experiments defined aminoacyl-tRNAs as the substrates for CDPSs (7) and suggested a sequential mechanism for tRNA binding and cYY formation for Rv2275 (10) . To assess the catalytic mechanism of YvmC-Blic, we performed biochemical assays to define the origins of the incorporated amino acids. Because YvmC-Blic preferentially produces cyclo-L-leucyl-L-leucine, we employed stable isotope 13 C-labeled Leu and tRNA Leu . By reacting the labeled [ 13 C] Leu (Leu*) with purified B. licheniformis tRNA Leu and LeuRS, we produced Leu*-tRNA Leu , which was subsequently purified to remove traces of impurities, such as ATP and free Leu*. This purified Leu*-tRNA Leu was then reacted with YvmC-Blic in the presence of a 10-fold excess of unlabeled free Leu, to prevent the incorporation of Leu* liberated by the spontaneous deacylation of Leu*-tRNA Leu . The ester bond of aminoacyl-tRNAs is unstable and can be quickly hydrolyzed in in vitro assays. Our mass spectrometry analysis of the reaction revealed the incorporation of two Leu* residues in the final product (cL*L*). ATP was not necessary for cLL formation. The experiment using unlabeled Leu-tRNA Leu in the presence of a 10-fold excess of free Leu* produced unlabeled cLL (Fig. 3 A and Fig. S4 ). These results established that YvmC-Blic uses Leu-tRNA Leu as the sole substrate, with no free amino acids derived thereof.
Rv2275 reportedly forms a dimer, similar to the class Ic aaRSs, which must dimerize for tRNA binding (with the tRNA bound across both monomers) (15) (Fig. S5 ). In contrast, CDPS dimerization does not seem to be required for cYY formation, because the catalytic serine residues in both active sites are 50 Å apart and located on diametrically opposite surfaces of the dimer. The dimerization mode is drastically different from that of the class Ic aaRSs (even considering the atypical case of the mimivirus TyrRS) and thus is incompatible with a similar tRNA-binding mode (Fig. S5) . Therefore, we analyzed the oligomeric states of the B. licheniformis (YvmC-Blic) and B. subtilis (YvmC-Bsub) CDPSs, which share 70% sequence identity (Table S2 ) by gel filtration. Both enzymes eluted as a single peak, with estimated M r of 31 and 29 kDa, respectively (Fig. 3B) . These values are very close to their theoretical M r of 29.6 kDa and clearly indicate a monomeric state. The ability of YvmC-Blic to crystallize with different intermolecular contacts also supports this view (Fig. S1) . We further determined the stoichiometry of tRNA binding for both enzymes by using the cognate tRNA Leu . The B. licheniformis and B. subtilis tRNA Leu molecules share the same 89-nucleotidelong sequence, with a M r of 30 kDa. The tRNA migrated on the column with an apparent M r of 46 kDa, probably due to its L-shape. The YvmC-Blic∶tRNA Leu and YvmC-Bsub∶tRNA Leu complexes migrated with estimated M r of 80 and 71 kDa, respectively, compatible with a 1∶1 complex of CDPS and tRNA (Fig. 3B) . These results revealed that the aminoacylated state of the tRNA is not critical for the binding by CDPSs. The inability of YvmC-Blic and YvmC-Bsub to dimerize and to bind two tRNA Leu molecules simultaneously implies a sequential mechanism for cLL production from Leu-tRNA Leu .
Critical Residues for Catalysis. Based on the structure of YvmC-Blic and the sequence conservation among the CDPSs, we designed a series of point mutants and a loop-deletion mutant to elucidate In the presence of tRNA Leu , YvmC-Bsub gave a single peak of the complex, whereas YvmC-Bsub gave two peaks, one corresponding to free tRNA Leu and the other to the complex (indicated with an arrow).
the catalytic mechanism (Fig. 4A) . We first tested the tRNA-binding ability of the mutants by a qualitative gel-shift assay. Most of the mutants were still able to bind the tRNA, albeit with lower affinity than the wild-type enzyme (Fig. S6A) . The tRNA-binding abilities of the Y180F and H205E mutants, the K88A/R98A double mutant and the loop-deletion mutant were significantly decreased, suggesting the involvement of these residues in tRNA binding. We next measured the cLL biosynthetic activity of the mutants by thin layer chromatography (Fig. 4B and Fig. S6B ). The S37A, N40D, E184A, and E184Q mutants, which are all able to bind tRNA Leu , had almost no activity, suggesting their critical role in the catalytic mechanism. The Y204A and Y204F mutants showed strong defects, while the K88A/R98A, R158A, Y180A, H205, and the loop-deletion mutants showed only moderate defects. The negative impact of the Tyr180 and Glu184 mutations supports their role in the recognition of the leucyl amide group. The mild effects of the tRNA binding impaired mutants on the enzyme catalytic activity confirmed their function in tRNA recognition. In addition, the reaction mixtures of the Y180A, E184A, Y204A, and Y204F mutants contained residual Leu-tRNA Leu molecules after a 30 min reaction, probably due to the protection of the ester bond from spontaneous deacylation (Fig. S6B) . These results suggest that Tyr180, Glu184, and TyrY204 are involved in the latter step of catalysis rather than the initial substrate binding. Ser37 and Asn40, and to a lesser extent, His205 and Tyr204, are close together in the catalytic pocket (Fig. 2E) , and their mutations impaired the cLL formation activity of YvmC-Blic (Fig. 4B ). This residue arrangement reminded us of the catalytic Ser, Glu, His triad found in the TE domain of NRPS (4). This domain is located in the terminal module of the NRPSs and catalyzes the final peptide release, which is covalently attached to the triad Ser residue by either hydrolysis or macrocyclization. Furthermore, Ser37 is located within a GxSxP/G motif, in a loop between the β1 strand and the α2 helix, which is a similar pattern to that of the catalytic serine residue from the hydrolases, located within a GxSxG consensus motif (16) . These analogies led us to hypothesize that the aminoacyl moiety of Leu-tRNA Leu is transferred to the Ser37 hydroxyl group. Indeed, we detected an aminoacyl-CDPS intermediate by SDS/PAGE using radiolabeled aminoacyl-tRNAs and short incubation times (Fig. 4C) . The reaction intermediate was not detected with the Ser37 and Asn40 mutants. Furthermore, the enzyme activity was maintained after the replacement of Ser37 by a cysteine residue, supporting the assignment of this serine residue as the acylation site (17) . The lack of intermediate formation by the S37C mutant after a 30-s incubation time is probably due to the low reactivity of the sulfhydryl group in this structural context. However, several differences were observed between YvmCBlic and the NRPS TE domain. First, in YvmC-Blic, the His205 mutation has only a mild effect on the reaction, whereas the His residue in the catalytic triad of the TE domain is critical for the activity. Second, the Asn40 of YvmC-Blic cannot be replaced by Asp, suggesting a CDPS-specific role for its amide group (Fig. 4B) , whereas the triad Asp from the TE domain is strictly conserved and critical for the enzyme activity. Third, PMSF, a well-known serine protease inhibitor that also inhibits the TE domain activity (18), does not inhibit the cyclodipeptide formation by YvmC-Blic (Fig. 4B) . Fourth, YvmC-Blic uses aminoacyltRNAs as acyl-carriers, in contrast to the phosphopantetheinyl arm of the NRPS TE domain. Fifth, the YvmC-Blic structure is unrelated to the α/β hydrolase fold of the TE domains (19) (Fig. S7) . Thus, although the CDPSs and the NRPS TE domains can form similar aminoacyl-enzyme intermediates through a conserved Ser residue, the catalytic mechanism of cyclodipeptide formation by CDPSs should be rather different from that of the NRPS TE domains for cyclization and product release.
Proposed Catalytic Mechanism. Vetting et al. proposed a catalytic mechanism for cYY formation by Rv2275, in which the catalytic serine hydroxyl group attacks the first Tyr-tRNA Tyr to form an Rv2275-Tyr intermediate (10) . The active site is then rearranged, with the rotation of the serine-tyrosyl ester from the catalytic pocket to a so-called "second surface depression" (Fig. S2F) . The emptied catalytic pocket accommodates the second Tyr-tRNA Tyr , which is then coupled with the first tyrosine to generate the tRNA-bound dityrosine. Finally, the enzyme assists in deprotonating the 3′ hydroxyl group of the tRNA and the dipeptide cyclize when it adopts the cis conformation.
The present YvmC-Blic structure and our mutational analysis support a similar mechanism for the first reaction step (i.e., the binding of Leu-tRNA Leu and the transfer of its aminoacyl moiety onto the conserved Ser37 residue). However, the following three observations led us to propose a different chemistry for the second step. First, the second surface depression in both Rv2275 and YvmC-Blic is positively charged (Fig. S2 F and G) and thus seems more suitable for binding the terminal nucleotide of the tRNA. Second, the cyclodipeptides formed by a given CDPS enzyme almost always have one amino acid in common [e.g., YvmC-Blic generates mostly cLL, cLF(phenylalanine) and cLM(methionine), with all three cyclodipeptide having one leucine residue in common] (7). Third, our mass spectrometric trials failed to detect a dileucine-tRNA intermediate in the reaction mixture, although it was predicted to exist as an intermediate in the catalytic mechanism proposed by Vetting et al. (10) . Therefore, we believe that only the "common" aminoacyl group binds and remains in the catalytic pocket as the first amino acid, whereas the second aminoacyl group is accommodated at a different site with less stringent recognition. Indeed, sufficient space is available above the first aminoacyl moiety-binding site in the YvmC-Blic structure (Fig S2G) .
Altogether, we propose the following catalytic mechanism (Fig. 5) : Upon Leu-tRNA Leu binding, the leucine amino group is appropriately positioned to hydrogen bond with the side chains of Glu184 and Tyr180 (step 1). The ester carbonyl is polarized by the Asn40 amide group, which facilitates the nucleophilic attack by the Ser37 hydroxyl group. The initial transesterification does not require Glu184 (step 2). The inability of the S37A and N40D mutants to form the Leu-CDPS covalent intermediate, in contrast to the E184 and E184Q mutants, supports the first step of the reaction mechanism. Subsequently, the second LeutRNA Leu binds, and its amino group interacts with the Glu184 carboxyl group (step 3). The amino group of the first leucine attacks the carbonyl ester of the second Leu-tRNA Leu , to generate an enzyme-bound dileucine (step 4). Finally, the dileucine adopts a cis conformation, probably due to the small volume of the catalytic pocket, which allows rapid and spontaneous cyclization by the attack of the second leucine's amide group on the first leucine's ester carbonyl (step 5). The absence of cLL formation by the E184A and E184Q mutants, despite the formation of the Leu-CDPS intermediate, supports the second step of our proposed reaction mechanism.
Perspectives. Several aspects remain unclear. The impact of aminoacyl-tRNA binding on the enzyme structure is unknown, but some remodeling seems to be required to allow access to the catalytic pocket. The CDPS specificity for the tRNA sequences also remains to be determined. AaRS domain paralogs performing functions other than the canonical aminoacylation have been identified in various organisms (20) ; however, these paralogs have generally retained the ability to activate their cognate amino acids. In contrast, the CDPS enzymes have lost the amino acid activation activity and have acquired broader or different amino acid specificities. Indeed, they can bind and process Tyr-(Rv2275) and Trp-tRNAs, as suggested by their structural similarity to the class Ic aaRSs, as well as Leu-(YvmC-Blic), Met-, and Phe-tRNAs (7) . With so few examples of CDPSs presently available, the evolutionary history of this protein family is obscure. The apparently scarce distribution of CDPS genes in bacterial genomes, and potentially in other phyla, is also puzzling. A structure-based phylogenetic analysis of the YvmC-Blic and Rv2275 enzymes placed them at the junction between the TyrRSs and TrpRSs, suggesting an ancient origin preceding the class Ic aaRS differentiation event (Fig. S8 ). It will also be interesting to test whether the gene products identified in archaea and eukaryotes (e.g., the sea anemone Nematostella vectensis) are indeed active CDPSs.
Such small proteins are easy to produce and manipulate and thus could be used for the synthesis of cyclodipeptides. This could provide access to a larger repertoire of scaffolds for the development of new, potentially therapeutic molecules. Understanding the catalytic mechanism of CDPS is the first step toward the engineering of enzymes producing desired cyclodipeptides.
Materials and Methods
YvmC-Blic Cloning, Expression, and Purification. The B. licheniformis gene yvmC was cloned in the pET22b vector and was used to transform Escherichia coli BL21 (DE3) Rosetta 2 cells. The protein expression was induced for 16 h at 20°C, with 1 mM IPTG in LB medium. The cells were harvested by centrifugation and resuspended in buffer A (100 mM Tris-HCl, pH 8.8, 300 mM NaCl, 10 mM β-ME, 10% glycerol, 20 mM imidazole) supplemented with 1 mM PMSF. After sonication, the lysate was centrifuged at 40;000 × g for 20 min at 4°C. The supernatant was mixed with 1 ml of NiNTA superflow resin (Qiagen) per liter of culture, incubated for 30 min at room temperature, and then loaded on an Econo column (Bio-Rad). After washing the column with 20 column volumes (c.v.) of buffer A, the bound recombinant protein was eluted with 5 c.v. of buffer A, supplemented with 500 mM imidazole. The fractions containing the recombinant protein were detected by a Bradford assay, pooled and supplemented with 0.5 volumes of buffer B (50 mM Tris-HCl, pH 8.8, 10 mM MgCl 2 , 5% glycerol, 10 mM β-ME), thus reducing the NaCl concentration to 200 mM. The diluted sample was loaded onto a 10 ml Hitrap Heparin HP column (GE Healthcare), equilibrated in buffer B supplemented with 200 mM NaCl. The protein was eluted with a linear gradient of 0.2 to 1 M NaCl. The fractions containing the protein were then pooled and fractionated on a HiLoad 16∕60 Superdex 75 prep grade column (GE Healthcare), equilibrated in buffer C (15 mM Tris-HCl, pH 8.8, 150 mM NaCl, 10 mM MgCl 2 , 2 mM DTT, 5% glycerol). The recombinant protein eluted with an apparent M r of 31 kDa, consistent with the monomeric form in solution. The protein was finally concentrated with an Amicon Ultra-4 10,000 MWCO filter (Millipore) to a 12 mg∕ml final concentration. Samples were either directly used for crystallization or flash-frozen as 25 μl aliquots in liquid nitrogen and stored at −80°C.
Mass Spectrometric Analysis of Cyclodipeptide Formation. The cyclodipeptide formation was performed basically according to the literature (7), with slight modifications. The reaction mixture, consisting of 100 mM Tris-HCl, pH 8.8, 150 mM NaCl, 10 mM MgCl 2 , 2.5 μM ([ 13 C 6 , 15 N]-labeled or nonlabeled) Leu-tRNA Leu , 25 μM Leu, and 5 nM YvmC-Blic, was incubated at 30°C for 30 min. Formic acid was added to a final concentration of 2% (v∕v) to stop the reaction. The product was desalted by passage through a NuTip C-18 column (Glygen Corp.), dried and dissolved in 0.1% TFA. To analyze the cyclodipeptide, we employed a capillary LC nano ESI/mass spectrometry system, consisting of a quadrupole time-of-flight (QqTOF) mass spectrometer (QSTAR®XL, Applied Biosystems) and a splitless nanoflow HPLC system (DiNa, KYA Technologies). The product was loaded onto a trap column packed with C18 reverse-phase resin, for desalting with 0.1% TFA, and then was directly injected into a C18 capillary column (HiQ Sil, 5 μm C18, 100 Å pore size; Φ0.1 × 100 mm, KYA Technologies) and fractionated at a flow rate of 300 nl∕ min, with a linear gradient of 10-98% Solvent B for 30 min. The solvent system consisted of 0.1% formic acid and 2% acetonitrile (Solvent A) and 0.1% formic acid and 80% acetonitrile (Solvent B). The applied voltage on the sprayer was set at þ2.2 kV, to generate a nanoelectrospray. TOF MS and product ion spectra were acquired in the positive mode, using the information-dependent data acquisition (IDA) program of the Analyst QS software (Applied Biosystems). The mass ranges for the full scan and the collision-induced dissociation (CID) were set to m∕z 200-500 and m∕z 50-500, respectively. The collision energy for CID was set at þ20-25 V, to obtain the product ions of the cyclodipeptide. The CID spectra were assigned according to the literature (7).
YvmC-Blic Crystallization. Screening of crystallization conditions was performed at 20°C and 4°C using the sitting drop vapor diffusion method. The drops were prepared by mixing equal amounts (100 nl þ 100 nl) of the protein and crystallization solutions using a Mosquito robot (TTP Labtech). Initial crystals were obtained from drops with the crystallization solution containing 100 mM CHES, pH 9.5, and 20% PEG 8,000. Large crystals were obtained using the hanging drop vapor diffusion method with 2 μl drops (1 μl þ 1 μl) . The crystals grew to maximum dimensions of 0.5 × 0.2× 0.2 mm 3 within 4 days. Cocrystallization and soaking were performed with the small ligands L-leucine, L-phenylalanine, puromycin, L-leucyl-L-leucine, L-leucyl-N-2′-adenylate, L-leucyl-L-leucyl-N-2′-adenylate, and cyclo-L-leucyl-L-leucine. For soaking, the CHES buffer was replaced by either CAPSO or Bis-Tris, pH 9.5. Structure Determination and Refinement. A SeMet-substituted crystal of YvmC-Blic was soaked in the crystallization buffer, cryoprotected with 20% glycerol and flash-cooled in a nitrogen stream at 100 K. A SeMet derivative dataset was collected at 0.97904 Å wavelength at the SPring-8 BL41XU beamline, using an ADSC Q315 CCD detector and was processed at 2.8-Å resolution with HKL2000 (21) . Among the 18 potential selenium sites, 10 were found with SHELXC/D (22) and were used for phase calculations at 4.0-Å resolution with the SHARP program (23) . The initial phases were improved by density modification with RESOLVE (24) . The initial model, containing 75% of all residues, was automatically built with RESOLVE. The model was further built manually using Coot (25) and improved by iterative cycles of refinement with Phenix (26) . The structures of the native, CHES-and CAPSO-complexed CDPSs were solved by molecular replacement at 1.9-, 1.7-, and 2.4-Å resolutions, respectively, using the model determined by single-wavelength anomalous diffraction phasing as a search model. Model building and structure refinement were performed with Coot and Phenix, respectively. The quality of the final models was assessed with MolProbity (27) . A summary of the structure refinement statistics is provided in Table S1 .
Blic-YvmC mutants, Bsub-YvmC, B. licheniformis LeuRS and aminoacyltRNA preparations, gel-shift assays, gel filtration assays, thin layer chromatography, SDS/PAGE analysis of reaction intermediates, and phylogenetic tree construction are described in SI Text.
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Bonnefond et al. 10 .1073/pnas.1019480108 SI Material and Methods B. licheniformis Cyclodipeptide Synthase Mutant Preparations. Point mutations were introduced in the yvmC gene-containing vector by the Quikchange method (Stratagene). The presence of the desired mutation was verified by sequencing. The mutants were purified on a NiNTA column in a similar manner to the wild-type protein, starting from 100 ml cultures. The purified proteins were concentrated, supplemented with 50% glycerol, and stored at −20°C until use.
Cloning, Expression, and Purification of Bacillus subtilis Cyclodipeptide Synthase. The yvmC gene from B. subtilis was cloned in the pET22b vector and used to transform Escherichia coli BL21 (DE3) Rosetta 2 cells. The protein expression was induced for 16 h at 20°C with 1 mM IPTG in LB medium. The purification protocol was similar to that used for YvmC-Blic. The protein was concentrated with an Amicon Ultra-4 10,000 MWCO filter (Millipore) to 10 mg∕ml. Samples (25 μl aliquots) were flashfrozen in liquid nitrogen and stored at −80°C.
Gel Filtration Experiments. YvmC-Blic and YvmC-Bsub were analyzed on a HiLoad 16∕60 Superdex 75 prep grade column (GE Healthcare), equilibrated in 10 mM Tris-HCl, pH 8.5, 150 mM NaCl and 2 mM DTT. The sample volumes were of 3 to 4 ml, at a 40 μM concentration. The columns were calibrated with 50 μl of Gel Filtration Standards (Bio-Rad). Free tRNA Leu and CDPS∶tRNA Leu complex samples (20 μl; 1∶1.2 ratio) were analyzed on a Superdex 75 10∕300 GL column (GE Healthcare), equilibrated in 10 mM Tris, pH 8.8, 150 mM NaCl, 10 mM MgCl 2 , 2 mM DTT and 5% glycerol. The free tRNA Leu concentration was 40 μM. The concentrations of YvmC-Blic and YvmC-Bsub for the complexes were 250 μM and 100 μM, respectively. The column was calibrated with 50 μl of Gel Filtration Standards (BioRad).
Cloning, Expression, and Purification of Bacillus licheniformis leucyltRNA Synthetase. The B. licheniformis LeuRS gene was cloned in the pET22b vector and used to transform E. coli Rosetta 2 (DE3) cells. The protein expression was induced for 4 h at 37°C, with 0.5 mM IPTG in LB medium. Cells were harvested by centrifugation and resuspended in buffer A (100 mM Tris-HCl, pH 8.0, 300 mM NaCl, 10 mM β-ME, 10% glycerol, 20 mM imidazole) supplemented with 1 mM PMSF. After sonication, the lysate was centrifuged at 40;000 × g for 20 min at 4°C. The supernatant was mixed with 1 ml of NiNTA superflow resin (Qiagen) per liter of culture, incubated for 30 min at room temperature and loaded on an Econo Column (Bio-Rad). After washing the column with 20 c.v. of buffer A, the bound recombinant protein was eluted with 5 c.v. of buffer A supplemented with 500 mM imidazole. The fractions containing the recombinant protein were detected by a Bradford assay, pooled, dialyzed against 25 mM Tris-HCl, pH 8.0, 5 mM MgCl 2 , 5 mM β-ME, and 50% glycerol, and stored at −20°C.
Preparation of Aminoacyl-tRNAs. The aminoacyl-tRNAs used for cyclodipeptide formation were prepared as follows. The in vitro transcribed (1) For the PMSF inhibition assay, the wild-type enzyme was preincubated with 5 mM PMSF for 5 min before starting the reaction. The reaction mixtures were analyzed by thin layer chromatography on 20 × 20 cm glass plates with a silica gel 60 matrix (Merck). For each enzyme, 2 μl of the reaction mixture were spotted on the plate, which was developed with a mobile phase [n-butanol (Nacalai Tesque)-acetic acid (Nacalai Tesque)-water (Millipore MiliQ™) (4∶1∶1)] for 4 h. After drying, the plates were exposed overnight to Image Plates (BAS-IIIs, Fujifilm) and developed with a Typhoon FLA-7000 apparatus (Fujifilm). The intensities of the spots were quantified with the Multigauge v3.6 program (Fujifilm). Experiments were performed in triplicate.
SDS/PAGE Analysis of Reaction Intermediates. Cyclodipeptide cLL formation was performed for 30 s at 30°C, in 5 μl reaction mixtures containing 50 mM Tris-HCl, pH 8.0, 150 mM NaCl, 10 mM MgCl 2 , 0.5 μM wild-type or mutant YvmC-Blic, and a fixed amount of [
14 C]Leu-tRNA Leu . The reactions were stopped by the addition of an equal volume of SDS/PAGE loading buffer and heated for 3 min at 95°C. The samples were fractionated, together with a High-range Rainbow ladder (GE Healthcare), on a denaturing 10% polyacrylamide gel. After migration, the gel was washed twice with 100 ml 50 mM Tris-HCl, pH 7.5. The gel was dried for 60 min at 80°C, exposed to an Image Plate for 4 days (BAS-IIIs, Fujifilm) and visualized with an FLA-2000 apparatus (Fujifilm). Experiments were performed in triplicate.
Phylogenetic Tree. The YvmC-Blic sequence was used to initiate a DALI search (2). The structure-based multiple sequence alignment, generated by DALI, contains the sequences from YvmC-Blic, Rv2775, 13 TyrRS sequences and 13 TrpRS sequences with the highest Z scores and was manually edited to remove all gaps. This 96 residue-long alignment was used to compute a distance matrix with protdist (3) and a bootstrapping value of 1,000 replicates. A Neighbor Joining consensus tree was built with the neighbors (3) and rendered with drawtree (3). All steps were performed on the Mobyle@pasteur platform (4).
All structure figures were generated with the PyMOL software (Schrödinger, LLC). The structure superimpositions were performed with the SSM algorithm (5). The electrostatic potential surfaces were calculated with the APBS plugin (6) , and the catalytic pocket shapes were rendered with HOLLOW (7). (7) or predicted (? mark), TyrRSs (YRS), and TrpRSs (WRS) are grouped and labeled with their species abbreviations. Each group is colored with a zappo color scheme, and the conservation index (1) is used to modify the shading intensity of the colors. The alignment was constructed using T-coffee (2) and was manually edited with Jalview (3). The secondary structure of YvmC-Blic was drawn with ESPript (4). The "XXX" triplet denotes a long insertion only present in one sequence. The species names are: Amir, Actinosynnema mirum; Aper, Aeropyrum pernix; Becr, Bacillus cereus; Blic, Bacillus licheniformis; Bsub, Bacillus subtilis; Bthu, Bacillus thuringiensis; BACT, Bacteroides sp.; BURK, Burkholderia sp.; Cjei, Corynebacterium jeikeium; Daes, Desulfovibrio aespoeensis; Gkau, Geobacillus kaustophilus; Gzae, Gibberella zeae; Mbov, Mycobacterium bovis; Mtub, Mycobacterium tuberculosis; Nvec, Nematostella vectensis; Ndas, Nocardiopsis das- YvmC-Blic and tRNA Leu molecules were incubated in 50 mM Tris-HCl, pH 8.8, 100 mM NaCl and 10 mM MgCl 2 for 20 min at 30°C, in a 10 μl reaction mixture. The tRNA Leu concentration was 4 μM and the CDPS concentration was 12 μM. The reaction mixture was supplemented with 10 μl of 60% glycerol, loaded onto a 6% native polyacrylamide gel and fractionated for 90 min at 100 V. After migration, the gel was stained with bromophenol blue to reveal the nucleic acids. Experiments were performed in duplicate. (B) TLC analysis of cLL formation by YvmC-Blic mutants. In addition to the wild-type and mutant molecules, the reaction was also performed in the absence of enzyme (control). One μl of the [ 14 C]Leu stock was also spotted (Leu). The difference in the free leucine migration height is due to the composition of the CDPS reaction buffer versus the [ 14 C]Leu solution (water:ethanol, 98∶2 ratio). 
